Diogo Magalhães

Statistics

Publications

Citations

223

H-Index

Active since

2018

Affiliations

Universidade do Porto(Current)

Inserm

Bial (Portugal)

French Clinical Research Infrastructure Network

Centre d’Investigation Clinique 1436

Diogo Magalhães is an author at Universidade do Porto specializing in parkinson's disease pharmacotherapy, parkinson disease, and parkinson’s disease pharmacotherapy.

ORCID

Publications per year

2018–2023

Publications

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Heinz Reichmann, Andrew J. Lees, José‐Francisco Rocha et al. · Translational Neurodegeneration · 2020 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

<i>Melissa officinalis</i>L. ethanolic extract inhibits the growth of a lung cancer cell line by interfering with the cell cycle and inducing apoptosis

Diogo Magalhães, Inês Castro, Vanessa Lopes-Rodrigues et al. · Food & Function · 2018 · 44 citations · Full text

Life Sciences, Botany, Plant Sciences +7

The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers

Eduardo Tolosa, Georg Ebersbach, Joaquim J. Ferreira et al. · Journal of Parkinson s Disease · 2021 · 23 citations · Full text

Pharmacy, Neurology, Health Assessment +16

Yield of ‘Prata-Anã’ banana plants under water deficit and high plant density

Diogo Magalhães, Sérgio Luíz Rodrigues Donato, Marcelo Rocha dos Santos et al. · Revista Brasileira de Fruticultura · 2020 · 19 citations · Full text

Agriculture, Agronomy, Crop Sciences +16

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II

José‐Francisco Rocha, Georg Ebersbach, Andrew J. Lees et al. · Frontiers in Neurology · 2021 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 9